Vorwald Charlotte E, Ho Steve S, Whitehead Jacklyn, Leach J Kent
Department of Biomedical Engineering, University of California-Davis, Davis, CA, USA.
Department of Orthopaedic Surgery, School of Medicine, University of California-Davis, Sacramento, CA, USA.
Methods Mol Biol. 2018;1758:139-149. doi: 10.1007/978-1-4939-7741-3_11.
Mesenchymal stem cells (MSCs) are a promising cell source for tissue repair and regeneration due to their multilineage capacity, potential for autologous use, and secretion of potent bioactive factors to catalyze the endogenous repair program. However, a major limitation to current cell-based tissue engineering approaches is the drastic loss of cells upon transplantation. The causation of this loss, whether due to apoptosis following a dramatic change in the microenvironment or migration away from the defect site, has yet to be determined. MSCs formed into aggregates, known as spheroids, possess a strong therapeutic advantage compared to the more commonly used dissociated cells due to their improved resistance to apoptosis and increased secretion of endogenous trophic factors. Furthermore, the use of biomaterials such as alginate hydrogels to transplant cells in situ improves cell survival, localizes payloads at the defect site, and facilitates continued instruction of cells by manipulating the biophysical properties of the biomaterial. Transplantation of MSC spheroids without a vehicle into tissue defects comprises the majority of studies to date, ceding control of spheroid function due to the cell's interaction with the native tissue extracellular matrix and abrogating the established benefits of spheroid formation. Thus, there is a significant need to consider the role of biomaterials in transplanting MSC spheroids using an appropriate carrier. In this chapter, we describe high-throughput formation of spheroids, steps for further characterization, and encapsulation in alginate hydrogels with an eye toward localizing MSC spheroids at the target site.
间充质干细胞(MSCs)因其多向分化能力、自体使用潜力以及分泌强效生物活性因子以催化内源性修复程序,而成为组织修复和再生中一种很有前景的细胞来源。然而,当前基于细胞的组织工程方法的一个主要限制是移植后细胞大量损失。这种损失的原因,无论是由于微环境急剧变化后的细胞凋亡还是从缺损部位迁移离开,尚未确定。与更常用的解离细胞相比,形成聚集体(即球体)的间充质干细胞具有强大的治疗优势,因为它们对细胞凋亡的抵抗力增强,内源性营养因子的分泌增加。此外,使用藻酸盐水凝胶等生物材料原位移植细胞可提高细胞存活率,将有效载荷定位在缺损部位,并通过操纵生物材料的生物物理特性促进对细胞的持续引导。迄今为止,大多数研究都是将没有载体的间充质干细胞球体移植到组织缺损中,由于细胞与天然组织细胞外基质的相互作用而放弃了对球体功能的控制,并消除了球体形成的既定益处。因此,迫切需要考虑生物材料在使用合适载体移植间充质干细胞球体中的作用。在本章中,我们描述了球体的高通量形成、进一步表征的步骤以及封装在藻酸盐水凝胶中,旨在将间充质干细胞球体定位在靶位点。